Coordinated Regulation of Serum- and Glucocorticoid-inducible Kinase 3 by a C-terminal Hydrophobic Motif and Hsp90-Cdc37 Chaperone Complex*

Autor: Len Neckers, Yuanzhong Wang, Wanping Xu, Dujin Zhou, Shiuan Chen
Jazyk: angličtina
Rok vydání: 2013
Předmět:
Proteasome Endopeptidase Complex
Chaperonins
Lactams
Macrocyclic

Ubiquitin-Protein Ligases
Amino Acid Motifs
Cell Cycle Proteins
Mitogen-activated protein kinase kinase
Protein Serine-Threonine Kinases
Biochemistry
Mass Spectrometry
MAP2K7
3-Phosphoinositide-Dependent Protein Kinases
Mice
Structure-Activity Relationship
Cell Line
Tumor

Enzyme Stability
Protein Interaction Mapping
Benzoquinones
Animals
Humans
ASK1
HSP90 Heat-Shock Proteins
Phosphorylation
Molecular Biology
biology
MAP kinase kinase kinase
Cyclin-dependent kinase 4
Cyclin-dependent kinase 2
Ubiquitination
Estrogens
Cell Biology
Cell biology
Protein Structure
Tertiary

Enzyme Activation
Protein Synthesis and Degradation
Drug Resistance
Neoplasm

Proteolysis
biology.protein
Cyclin-dependent kinase complex
Cyclin-dependent kinase 9
Hydrophobic and Hydrophilic Interactions
Chromatography
Liquid

Protein Binding
Popis: Serum- and glucocorticoid-inducible kinase 3 (SGK3) mediates a variety of cellular processes including membrane transport, cell proliferation, and survival, and it has been implicated in Akt-independent signaling downstream of oncogenic PIK3CA mutations (activating mutations in the α catalytic subunit of PI3K) in human cancers. However, the regulation of SGK3 is poorly understood. Here we report that SGK3 stability and kinase activation are regulated by the Hsp90-Cdc37 chaperone complex. Hsp90-Cdc37 associates with the kinase domain of SGK3 and acts in concert with a C-terminal hydrophobic motif of SGK3 to prevent Hsp70 association and ubiquitin ligase CHIP (C terminus of Hsc70-interacting protein)-mediated degradation. Phosphorylation of hydrophobic motif triggers release of Cdc37 and concomitant association of 3-phosphoinositide dependent kinase 1 (PDK1) to activate SGK3. Our study provides new insights into regulation of SGK3 stability and activation and the rationale for application of Hsp90 inhibitors in treating SGK3-dependent cancers.
Databáze: OpenAIRE